Investigation Support Multidisciplinary Unit for Primary care in Madrid, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, Spain.
CHNP, Rehaklinik, Ettelbruck, Luxembourg.
Eur J Gen Pract. 2024 Dec;30(1):2409240. doi: 10.1080/13814788.2024.2409240. Epub 2024 Oct 22.
The COVID-19 vaccination campaign in several European countries involved collaboration between public health and Primary Health Care (PHC).
To highlight the role of PHC professionals in the COVID-19 vaccination rollout, specifically in terms of vaccine administration, communication and contributing to vaccination population coverage.
A descriptive retrospective study of the COVID-19 vaccination campaign across 28 European countries was conducted, covering data from December 2020 to November 2021. Data were collected by key informants recruited from each country, who were health professionals involved in their national vaccination campaigns. Utilising an ad-hoc semi-structured questionnaire, information was gathered on organisation, communication strategies, priority groups, vaccine types, and vaccination pathways in PHC.
PHC participated in communication strategies in 10 out of 28 countries, and vaccination was voluntary in most of them. The priority groups for vaccination varied across Europe, and the availability of vaccines in PHC differed between countries within the European Union (EU) and non-EU countries. The BioNTech Pfizer vaccine was the most widely available vaccine in most countries, followed by Moderna and AstraZeneca. PHC administered COVID-19 vaccines to the population, being the nurses the most involved, followed by general practitioners. Vaccination appointments were available online in 18/28 or by phone in 15/28, direct appointments at health centres were available in 8/28. In several countries, healthcare professionals who administered vaccines were given extra compensation for their role.
PHC professionals played a crucial role in the successful distribution and administration of COVID-19 vaccines in European countries.
在一些欧洲国家,COVID-19 疫苗接种计划涉及公共卫生和初级卫生保健(PHC)之间的合作。
强调 PHC 专业人员在 COVID-19 疫苗接种推广中的作用,特别是在疫苗接种管理、沟通和提高疫苗接种人群覆盖率方面。
对 28 个欧洲国家的 COVID-19 疫苗接种运动进行了描述性回顾性研究,涵盖了 2020 年 12 月至 2021 年 11 月的数据。数据由从每个国家招募的主要信息员收集,他们是参与本国疫苗接种运动的卫生专业人员。利用专门的半结构化问卷,收集了 PHC 中的组织、沟通策略、优先群体、疫苗类型和接种途径的信息。
在 28 个国家中的 10 个国家,PHC 参与了沟通策略,而且大多数国家的疫苗接种都是自愿的。疫苗接种的优先群体在欧洲各地有所不同,欧盟(EU)内和非 EU 国家之间 PHC 中疫苗的供应情况也有所不同。在大多数国家,BioNTech Pfizer 疫苗是最广泛使用的疫苗,其次是 Moderna 和 AstraZeneca。PHC 为人群接种了 COVID-19 疫苗,其中护士参与最多,其次是全科医生。在 28 个国家中的 18 个国家可以在线预约接种疫苗,在 28 个国家中的 15 个国家可以通过电话预约,在 28 个国家中的 8 个国家可以直接在健康中心预约。在一些国家,接种疫苗的医疗保健专业人员因他们的角色获得了额外的补偿。
在欧洲国家,PHC 专业人员在 COVID-19 疫苗的成功分发和管理中发挥了关键作用。